Becton Dickinson & Co. closed 32.13% below its 52-week high of $251.99, which the company reached on February 3rd.

Becton, Dickinson and Company ( NYSE: BDX) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Tom Polen - Chairman, Chief Executive Officer and President ...

Becton Dickinson receives multiple downgrades as analysts cite weakening organic growth and trimmed price targets following a ...

Even though Becton, Dickinson and Company (NYSE:BDX) posted strong earnings, investors appeared to be underwhelmed. We have done some analysis and have found some comforting factors beneath the ...

Fintel reports that on May 2, 2025, Piper Sandler downgraded their outlook for Becton, Dickinson and (NYSE:BDX) from ...

Shares of Becton Dickinson & Co. BDX rose 1.20% to $167.14 Wednesday, on what proved to be an all-around great trading ...

Fintel reports that on May 1, 2025, William Blair downgraded their outlook for Becton, Dickinson and (NYSE:BDX) from ...

″‘Buying the dip’ depends upon your timeframe,” says Richard Smith, CEO of investing tool RiskSmith. “If you can keep your ...

Becton Dickinson recently announced mixed second-quarter financial results with increased sales but lower net income and EPS. Despite raising its earnings guidance slightly, the company's stock ...

Wells Fargo & Company downgraded shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) from an overweight rating to an equal weight rating in a report released on Thursday ...

Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research ...

We recently published a list of Jim Cramer Rediscovers Love For Magnificent 7 & Discusses These 11 Stocks In this article, we are going to take a look at where Becton, Dickinson and Company (NYSE:BDX) ...